Stephenson Pamela 4

What Happened
Pamela Stephenson, Chief Commercial Officer of Disc Medicine (IRON), received two equity awards on February 10, 2026: 17,000 restricted stock units (RSUs) and 25,500 derivative awards (option-like). Both awards were granted at $0.00 (no cash paid at grant); the filing does not state an immediate cash value or resulting change in share ownership.

Key Details

• Transaction date: 2026-02-10; Form 4 filed 2026-02-11 (timely filing).
• Awards: 17,000 RSUs (footnote F1) and 25,500 derivative award units/options (footnote F2).
• Grant price: $0.00 for both lines (standard for equity grants).
• Vesting: RSUs vest annually in four equal (25%) installments beginning Feb 15, 2027 (F1). The derivative award's underlying shares vest in 48 equal monthly installments beginning March 10, 2026 (F2).
• Shares owned after transaction: not specified in the filing.
• Transaction code: A = Award/Grant. No sale or exercise occurred.

Context
These are compensation awards rather than open-market purchases or sales. RSUs convert to shares as they vest; the derivative award appears to be an option or similar instrument whose shares vest monthly. Grants at $0.00 are common for employee compensation and do not by themselves indicate buying or selling activity.